Apellis Pharma
APLS41.0300.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Apellis Pharma(APLS) the Revenue is 268.3 M (+60.85%);the EBIT is 26.47 M (+131.8%);the EPS is 0.146 (+119.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.27B60.85%
----
----
EBIT
0.03B131.76%
----
----
EPS
0.1461119.74%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf